Patent details

EP3419593 Title: ENASIDENIB FOR USE IN THE TREATMENT OF RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA

Basic Information

Publication number:
EP3419593
PCT Application Number:
US2016064615
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP168168102
PCT Publication Number:
WO2017146794
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ENASIDENIB FOR USE IN THE TREATMENT OF RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA
French Title of Invention:
ÉNASIDÉNIB DESTINÉ AU TRAITEMENT DE LA LEUCÉMIE MYÉLOÏDE AIGUË RÉCIDIVANTE OU RÉFRACTAIRE
German Title of Invention:
ENASIDENIB ZUR BEHANDLUNG VON REZIVIDIERER ODER REFRÄKTARER AKUTER MYELOISCHER LEUKÄMIE
SPC Number:

Dates

Filing date:
02/12/2016
Grant date:
23/03/2022
EP Publication Date:
02/01/2019
PCT Publication Date:
31/08/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/03/2022
EP B1 Publication Date:
23/03/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
02/12/2022
Expiration date:
02/12/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/03/2022
 
 

Name:
Celgene Corporation
Address:
86 Morris Avenue, Summit, NJ 07901, United States (US)

Name:
Les Laboratoires Servier
Address:
50 rue Carnot, 92284 Suresnes Cedex, France (FR)

Inventor

1

Name:
WU, Bin
Address:
United States (US)

2

Name:
AMATANGELO, Michael
Address:
United States (US)

3

Name:
HU, Xiaolan
Address:
United States (US)

4

Name:
CHOE, Sung Eun
Address:
United States (US)

5

Name:
THAKURTA, Anjan
Address:
United States (US)

Priority

Priority Number:
201662300673 P
Priority Date:
26/02/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/365; A61K 31/404; A61K 31/437; A61K 31/44; A61K 31/444; A61K 31/4709; A61K 31/496; A61K 31/497; A61K 31/5025; A61K 31/53; A61K 31/5377; A61K 31/551; A61K 31/553; A61K 45/06; A61K 9/00; A61P 35/00; A61P 35/02; C07D 251/52; C07D 401/14; C07D 403/14;

Publication

European Patent Bulletin

Issue number:
202212
Publication date:
23/03/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages